Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL CRITERIA NETWORK HELP ABOUT

Current criteria:

Regional:

WPRlM journal selection criteria(2023)

Minimum standards for the suspension and removal of WPRIM approved journals

Countries journal selection criteria:

Philippines

Submit your journal information>

Contact NJSCs>

International Journal of Arrhythmia

2002 (v1, n1) to Present ISSN: 1671-8925

Articles

About

Year of publication

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

221

results

page

of 23

1

Cite

Cite

Copy

Share

Share

Copy

Differential Diagnosis of Supraventricular Tachycardia.

Sung Won JANG

International Journal of Arrhythmia.2017;18(1):43-47. doi:10.18501/arrhythmia.2017.006

Supraventricular tachycardia (SVT) refers to a heterogeneous group of arrhythmias localized within the upper part of the heart (the His bundle or above). In general, the term SVT does not include atrial fibrillation. Common forms of SVT include atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia, focal atrial tachycardia, and atrial flutter. Other, less common arrhythmias also fall under the category of SVT, including inappropriate sinus tachycardia and junctional reentrant/ectopic tachycardia. Paroxysmal supraventricular tachycardia refers to AVNRT and AVRT. SVTs can be identified and classified by clinical manifestation/physical examination, ECG, and/or electrophysiologic analysis.
Arrhythmias, Cardiac ; Atrial Fibrillation ; Atrial Flutter ; Bundle of His ; Diagnosis, Differential* ; Electrocardiography ; Heart ; Tachycardia ; Tachycardia, Atrioventricular Nodal Reentry ; Tachycardia, Sinus ; Tachycardia, Supraventricular*

Arrhythmias, Cardiac ; Atrial Fibrillation ; Atrial Flutter ; Bundle of His ; Diagnosis, Differential* ; Electrocardiography ; Heart ; Tachycardia ; Tachycardia, Atrioventricular Nodal Reentry ; Tachycardia, Sinus ; Tachycardia, Supraventricular*

2

Cite

Cite

Copy

Share

Share

Copy

Supraventricular Tachycardia by Concealed Bypass Tract.

Ki Hong LEE

International Journal of Arrhythmia.2017;18(1):38-42. doi:10.18501/arrhythmia.2017.005

Concealed bypass tract (CBT) results from incomplete development of the atrioventricular (AV) annulus. CBT conducts only in a retrograde direction, and therefore does not cause pre-excitation on standard electrocardiograms. The most common tachycardia associated with CBT is an orthodromic atrioventricular reentrant tachycardia (AVRT): a pathway involving anterograde circuitry through the AV node and His Purkinje system and retrograde conduction over the accessory pathway. Orthodromic AVRT accounts for approximately 90%-95% cases of AVRT. Most incidences of CBT occur at the left free wall. Vagal maneuvers and/or intravenous (IV) adenosine are recommended for first line acute management of AVRT. However, pharmacological therapy with IV diltiazem, verapamil, or beta blockers can also be effective for acute treatment for orthodromic AVRT in patients who do not show pre-excitation on their resting ECG during sinus rhythm. The first-line ongoing therapy for AVRT is catheter ablation of CBT; when catheter ablation is not indicated or preferred, oral beta blockers, diltiazem, verapamil, flecainide, propafenone, or amiodarone are recommended.
Adenosine ; Amiodarone ; Atrioventricular Node ; Catheter Ablation ; Diltiazem ; Electrocardiography ; Flecainide ; Humans ; Incidence ; Propafenone ; Tachycardia ; Tachycardia, Supraventricular* ; Verapamil

Adenosine ; Amiodarone ; Atrioventricular Node ; Catheter Ablation ; Diltiazem ; Electrocardiography ; Flecainide ; Humans ; Incidence ; Propafenone ; Tachycardia ; Tachycardia, Supraventricular* ; Verapamil

3

Cite

Cite

Copy

Share

Share

Copy

Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

Jumsuk KO

International Journal of Arrhythmia.2017;18(1):33-37. doi:10.18501/arrhythmia.2017.004

Atrioventricular nodal reentrant tachycardia is the most common type of supraventricular tachycardia. The initiation and maintenance of tachycardia is caused by the characteristic anatomic and electrophysiologic properties of the atrioverntricular node. Acute management for the termination of tachycardia includes pharmacologic and non-pharmacologic management. There are several options for preventing recurrence of tachycardia, and radiofrequency ablation for modulation of tachycardia circuit can be considered as a primary strategy. A thorough understanding of the unique electrophysiologic features is very essential for optimal management and best possible outcome in cases of invasive management.
Catheter Ablation ; Recurrence ; Tachycardia ; Tachycardia, Atrioventricular Nodal Reentry* ; Tachycardia, Supraventricular

Catheter Ablation ; Recurrence ; Tachycardia ; Tachycardia, Atrioventricular Nodal Reentry* ; Tachycardia, Supraventricular

4

Cite

Cite

Copy

Share

Share

Copy

CartoMerge using SoundStar Catheter and Time Force Integral-Based Ablation for Atrial Fibrillation.

Koichi INOUE

International Journal of Arrhythmia.2017;18(1):27-32. doi:10.18501/arrhythmia.2017.003

Catheter ablation for atrial fibrillation is based on pulmonary vein (PV) isolation, but this procedure is thought to be demanding. The visualization of 3-dimensional information that is provided by CartoMerge® (BioSense Webster Inc., Diamond Bar, CA, USA) makes the ablation procedure easier. The SoundStar® catheter (BioSense Webster Inc., Diamond Bar, CA, USA)became available in Korea in September 2016. CartoMerge® using a SoundStar® catheter, which we termed as SoundMerge, is a simple way to obtain good CartoMerge® results. In addition, information on catheter stability and ablation intensity at each site are provided by a new ablation annotation system (CARTO® 3 System, VisiTag™ Module [BioSense Webster Inc., Diamond Bar, CA, USA]), which would be helpful for accomplishing durable PV isolation. In this article, we introduce the methodology of SoundMerge and the setting of the VisiTag™ module that we are performing currently. Effective practical use of these new technologies would improve the quality of ablation procedures.
Atrial Fibrillation* ; Catheter Ablation ; Catheters* ; Diamond ; Korea ; Pulmonary Veins

Atrial Fibrillation* ; Catheter Ablation ; Catheters* ; Diamond ; Korea ; Pulmonary Veins

5

Cite

Cite

Copy

Share

Share

Copy

The Impact of the CHA₂DS₂-VASc Score on Recurrence of Atrial Fibrillation after a Single Catheter Ablation and Atrial Remodeling in Patients with Non-Valvular Atrial Fibrillation.

Chan Hee LEE ; Sang Hee LEE ; Kyu Hwan PARK ; Dong Gu SHIN

International Journal of Arrhythmia.2017;18(1):16-26. doi:10.18501/arrhythmia.2017.002

BACKGROUND AND OBJECTIVES: This study aimed to evaluate the impact of the CHA₂DS₂-VASc score on atrial fibrillation (AF) recurrence after a single catheter ablation procedure in patients with non-valvular AF. We also investigated the correlation between CHA₂DS₂-VASc score and atrial substrate. SUBJECTS AND METHODS: This study evaluated 151 patients who underwent catheter ablation of non-valvular AF. The study population was stratified into group 1 (<2, n=72) and group 2 (≥2, n=79) by CHA₂DS₂-VASc score. The CHA₂DS₂-VASc score was analyzed as a continuous and categorical value for evaluating its impact on AF recurrence after catheter ablation. The left atrial voltage data were analyzed by the categorical values of this score. RESULTS: Post-ablation recurrence (31.6% vs. 18.1%, p=0.046) was observed more frequently in group 2. The mean area of the lowvoltage zone was 75.64±24.81 cm² and 94.44±28.09 cm² in groups 1 and 2, respectively (p=0.005). The left atrial mean voltage in group 2 was 0.99±0.31 mV, significantly lower than that (1.49±0.67 mV, p=0.001) in group 1. The CHA₂DS₂-VASc score was the independent predictor with a modest predictive value for AF recurrence after catheter ablation. CONCLUSION: Our study showed that CHA₂DS₂-VASc score was associated with atrial remodeling and could be useful in stratifying post-ablation recurrence in patients with non-valvular AF.
Atrial Fibrillation* ; Atrial Remodeling* ; Catheter Ablation* ; Catheters* ; Humans ; Recurrence*

Atrial Fibrillation* ; Atrial Remodeling* ; Catheter Ablation* ; Catheters* ; Humans ; Recurrence*

6

Cite

Cite

Copy

Share

Share

Copy

Design of Korean Noninvasive Risk Evaluation Study for Sudden Cardiac Death from Infarction or Heart Failure: Myocardial infarction study of K-REDEFINE registry.

Seung Jung PARK ; Gyo Seung HWANG ; Gi Byoung NAM ; Hyung Wook PARK ; Joong Wha CHUNG ; Seung Yong SHIN ; Sang Min KIM ; Jun Hyung KIM ; Young Soo LEE ; Yae Min PARK ; Jong Youn KIM ; Dae Hyeok KIM ; Dae Kyeong KIM ; June NAMGUNG ; Dae Hee SHIN ; Joon Hyouk CHOI ; Hyoung Seob PARK ; Jong Il CHOI ; Jin Seok KIM ; Tae Joon CHA ; Sang Weon PARK ; Jae Sun UHM ; Nam Ho KIM ; Minsoo AHN ; Dong Gu SHIN ; Nuri JANG ; Meemo PARK ; June Soo KIM

International Journal of Arrhythmia.2017;18(1):6-15. doi:10.18501/arrhythmia.2017.001

BACKGROUND AND OBJECTIVES: Despite significant advances in the treatment of acute myocardial infarction (MI), the prevention of sudden cardiac death (SCD), the most common mode of death in patients with MI, remains challenging. Furthermore, previous Korean MI registries did not address the issue of post-MI SCD. Additional risk stratifiers of post-MI SCD are still required to compensate for the limitation of using left ventricular ejection fraction to predict lethal arrhythmic events. SUBJECTS AND METHODS: We designed the first Korean prospective nationwide multicenter registry primarily focused on SCD; the Korean noninvasive Risk Evaluation study for sudden cardiac DEath From INfarction or heart failurE (K-REDEFINE). The registry consists of 2 groups of patients presenting with (1) acute MI or (2) acute heart failure (HF) at 25 tertiary referral cardiovascular centers. The primary endpoint of the MI group study of K-REDEFINE registry is the incidence and risk factors of post-MI SCD. In particular, the association between the risk of SCD and non-invasive Holter-based electrocardiogram (ECG) variables will be evaluated, such as T-wave alternans (marker of repolarization heterogeneity) and heart rate turbulence/variability (a marker of autonomic function). Other secondary study outcomes include atrioventricular arrhythmias, HF-related admission, repeated myocardial ischemic events, stroke, and overall deaths. CONCLUSION AND PERSPECTIVE: The K-REDEFINE registry will provide new prospects for the better management of MI patients with high risk of SCD by clarifying the burden and predictors of SCD and the clinical utility of various non-invasive ambulatory ECG-based variables in risk stratification for SCD in this patient population.
Arrhythmias, Cardiac ; Death, Sudden, Cardiac* ; Electrocardiography ; Heart Failure* ; Heart Rate ; Heart* ; Humans ; Incidence ; Infarction* ; Myocardial Infarction* ; Prospective Studies ; Referral and Consultation ; Registries ; Risk Factors ; Stroke ; Stroke Volume

Arrhythmias, Cardiac ; Death, Sudden, Cardiac* ; Electrocardiography ; Heart Failure* ; Heart Rate ; Heart* ; Humans ; Incidence ; Infarction* ; Myocardial Infarction* ; Prospective Studies ; Referral and Consultation ; Registries ; Risk Factors ; Stroke ; Stroke Volume

7

Cite

Cite

Copy

Share

Share

Copy

Early Detection of Subclinical Atrial Flutter-Fibrillation in Patients with Unexplained Palpitation Using a Novel VDD Defibrillator with Integrated Atrial-Sensing Rings.

Seung Jung PARK

International Journal of Arrhythmia.2016;17(3):163-166. doi:10.18501/arrhythmia.2016.028

A 56-year-old man with an implantable cardioverter-defibrillator (ICD) presented with unexplained heart palpitations, which were usually aggravated after ingesting alcohol. He had a history of coronary artery bypass graft surgery 8 years ago, and an ICD was placed (i.e. a single ventricular shock coil with integrated atrial-sensing rings [VDD ICD lead]) 1.5 years ago for primary prevention of sudden cardiac death associated with ischemic cardiomyopathy. Repeated electrocardiograms and echocardiograms showed no evidence of atrial flutter-fibrillation; this was clearly demonstrated using several atrial electrogram strips during the ICD analysis.
Atrial Fibrillation ; Cardiomyopathies ; Coronary Artery Bypass ; Death, Sudden, Cardiac ; Defibrillators* ; Defibrillators, Implantable ; Electrocardiography ; Electrophysiologic Techniques, Cardiac ; Heart ; Humans ; Middle Aged ; Primary Prevention ; Shock ; Stroke ; Transplants

Atrial Fibrillation ; Cardiomyopathies ; Coronary Artery Bypass ; Death, Sudden, Cardiac ; Defibrillators* ; Defibrillators, Implantable ; Electrocardiography ; Electrophysiologic Techniques, Cardiac ; Heart ; Humans ; Middle Aged ; Primary Prevention ; Shock ; Stroke ; Transplants

8

Cite

Cite

Copy

Share

Share

Copy

Sinus Conversion of Atrial Fibrillation by Restoration of Atrial Perfusion in a Patient with Chronic Total Occlusion.

Aron JEONG ; Sung Soo KIM ; Semi KIM ; Dong Goo KANG ; Seung Wook LEE ; Sang Ki CHO

International Journal of Arrhythmia.2016;17(3):158-162. doi:10.18501/arrhythmia.2016.027

Atrial fibrillation (AF) is a common arrhythmia, and restoration of sinus rhythm is very important in treating this condition. Recently, we experienced a rare case of immediate cardioversion from AF after successful revascularization in a patient with chronic total proximal part of the right coronary artery (RCA) occlusion. A 72-year-old woman with hypertension and diabetes mellitus experienced chest discomfort. An electrocardiogram (ECG) revealed AF. Despite 3 months of appropriate pharmacologic therapy for AF, she continued to complain of effort angina, which was relieved by sublingual nitroglycerin. She subsequently underwent cardiac catheterization, which revealed chronic total occlusion of the proximal RCA with grade III collateral vessels from the left anterior descending (LAD) artery. Balloon angioplasty and stenting restored the blood flow of the RCA, and the AF promptly reverted to sinus rhythm. There was no recurrence of AF over 12 months of follow-up at the outpatient clinic.
Aged ; Ambulatory Care Facilities ; Angioplasty, Balloon ; Arrhythmias, Cardiac ; Arteries ; Atrial Fibrillation* ; Cardiac Catheterization ; Cardiac Catheters ; Coronary Occlusion ; Coronary Vessels ; Diabetes Mellitus ; Electric Countershock ; Electrocardiography ; Female ; Follow-Up Studies ; Humans ; Hypertension ; Myocardial Ischemia ; Nitroglycerin ; Perfusion* ; Recurrence ; Stents ; Thorax

Aged ; Ambulatory Care Facilities ; Angioplasty, Balloon ; Arrhythmias, Cardiac ; Arteries ; Atrial Fibrillation* ; Cardiac Catheterization ; Cardiac Catheters ; Coronary Occlusion ; Coronary Vessels ; Diabetes Mellitus ; Electric Countershock ; Electrocardiography ; Female ; Follow-Up Studies ; Humans ; Hypertension ; Myocardial Ischemia ; Nitroglycerin ; Perfusion* ; Recurrence ; Stents ; Thorax

9

Cite

Cite

Copy

Share

Share

Copy

Changes in Atrioventricular Node Physiology Following Slow Pathway Modification in Patients with AV Nodal Re-entrant Tachycardia: The Hypothetical Suggestion of Mechanism of Noninducibility of AVNRT.

Ju Youn KIM ; Sung Hwan KIM ; Tae Seok KIM ; Ji Hoon KIM ; Sung Won JANG ; Yong Seog OH ; Seung Won JIN ; Tai Ho RHO ; Man Young LEE

International Journal of Arrhythmia.2016;17(1):6-13. doi:10.18501/arrhythmia.2016.001

BACKGROUND AND OBJECTIVES: In cases of radiofrequency catheter ablation (RFCA) for patients with atrioventricular nodal re-entrant tachycardia (AVNRT), complete elimination of slow pathway is not always achievable. Furthermore, in situations of the so-called modified slow pathway, the underlying mechanism of tachycardia elimination remains unclear. SUBJECTS AND METHODS: Patients who underwent RFCA for AVNRT, and showed persistence of dual atrioventricular nodal physiology but no induction of AVNRT after ablation were enrolled. We measured electrophysiologic parameters before and after the ablation procedure. RESULTS: The study subjects included 31 patients (39% men; mean age 43±19 years). The RR interval, Wenckebach cycle length of AV node, slow pathway effective refractory period, maximal AH interval of fast pathway and slow pathway showed no significant changes before and after ablation. However, fast pathway effective refractory period (360±67 vs. 304±55, p<0.001) and differences between slow pathway effective refractory period and fast pathway effective refractory period (90±49 vs. 66±35, p=0.009) were decreased after slow pathway ablation. CONCLUSION: We suggest a possible relationship between the mechanism of tachycardia elimination in AVNRT and an alteration of the re-entrant circuit by removal of the atrial tissue in Koch's triangle. This may be a critical component of providing the excitable gap for the maintenance of tachycardia rather than the electrical damage of slow pathway itself.
Atrioventricular Node* ; Catheter Ablation ; Humans ; Male ; Physiology* ; Tachycardia*

Atrioventricular Node* ; Catheter Ablation ; Humans ; Male ; Physiology* ; Tachycardia*

10

Cite

Cite

Copy

Share

Share

Copy

Ondansetron Inhibits Voltage-Gated K⁺ Current of Ventricular Myocytes from Pregnant Mouse.

Shanyu CUI ; Hyewon PARK ; Hyelim PARK ; Dasom MUN ; Hyo Eun KIM ; Nuri YUN ; Boyoung JOUNG

International Journal of Arrhythmia.2017;18(2):77-84. doi:10.18501/arrhythmia.2017.012

BACKGROUND: The Htr3a antagonist, ondansetron, has been reported to prolong the QT interval and induce Torsades de pointes in the treatment of postoperative nausea and vomiting. To explore the mechanisms underlying these findings, we examined the effects of ondansetron on the mouse cardiac voltage-gated K⁺ (Kv) channel. METHODS AND RESULTS: Ondansetron increased QT intervals in late pregnant (LP) mice. We measured the Kv channels in freshly isolated left ventricular (LV) myocytes from non-pregnant (NP) and late pregnant (LP) mice, using patch-clamp electrophysiology. Ondansetron blocked Kv current at a dose of 50 µM, and reduced the amplitude of peak current densities in a dose-dependent manner (0, 1, 5, 50 µM), in LP but not in NP mice. In contrast, serotonin and the Htr3 agonist, m-CPBG, increased Kv current densities in NP, but not in LP mice. Interestingly, during pregnancy, serum serotonin levels were markedly increased, suggesting the saturation of the effect of serotonin. Immunostaning data showed that Kv4.3 protein and Htr3a co-localize at the membrane and t-tubule of cardiomyocytes. Moreover, Kv4.3 membrane trafficking was enhanced in response to Htr3a-mediated serotonin stimulation in NP, but not in LP mice. Membrane analysis showed that serotonin enhances Kv4.3 membrane trafficking in NP, but not LP mice. CONCLUSION: Ondansetron reduced Kv current densities, and reduced the Kv4.3 membrane trafficking in LP mouse ventricular cardiomyocytes. This data suggests that QT prolongation by ondansetron is mediated by the reduction of Kv current densities and Kv4.3 membrane trafficking.
Animals ; Electrophysiology ; Membranes ; Mice* ; Muscle Cells* ; Myocytes, Cardiac ; Ondansetron* ; Postoperative Nausea and Vomiting ; Pregnancy ; Serotonin ; Torsades de Pointes

Animals ; Electrophysiology ; Membranes ; Mice* ; Muscle Cells* ; Myocytes, Cardiac ; Ondansetron* ; Postoperative Nausea and Vomiting ; Pregnancy ; Serotonin ; Torsades de Pointes

Country

Republic of Korea

Publisher

ElectronicLinks

Editor-in-chief

E-mail

Abbreviation

International Journal of Arrhythmia

Vernacular Journal Title

ISSN

2466-0981

EISSN

Year Approved

2016

Current Indexing Status

Currently Indexed

Start Year

Description

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.